Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
Shamir N KalariaSarah WillifordDong GuoYan ShuChristopher MedlinMatthew LiSiu Yan Amy YeungFarhan AliWisna JeanMathangi GopalakrishnanMojdeh S HeavnerPublished in: Pharmacotherapy (2021)
Ceftaroline is cleared extensively in critically ill patients receiving CRRT and may impact pharmacodynamic target achievement. Dose adjustments should be based on the intensity of the CRRT regimen, patient weight, and the clinical status of the patient.